【制药网 行业动态】近年来,我国眼科疾病呈现显著变化,眼科疾病患者基数不断增长,涵盖了屈光不正、白内障、青光眼、干眼症等多种病症。与此同时,该病治疗市场规模也在快速增长,数据显示,中国眼科药物治疗市场规模已由2019年的202.82亿元增加至2023年的268.02亿元,复合年增长率为7.22%。目前,随着患者对眼科药物的需求不断增加,大批药企针对不同症状正在加速研发新药,满足患者的多样化需求。...
Source Link【制药网 行业动态】近年来,我国眼科疾病呈现显著变化,眼科疾病患者基数不断增长,涵盖了屈光不正、白内障、青光眼、干眼症等多种病症。与此同时,该病治疗市场规模也在快速增长,数据显示,中国眼科药物治疗市场规模已由2019年的202.82亿元增加至2023年的268.02亿元,复合年增长率为7.22%。目前,随着患者对眼科药物的需求不断增加,大批药企针对不同症状正在加速研发新药,满足患者的多样化需求。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.